# Phase 27 End-to-End Anti-Workaround Audit

**Contract:** `phase27-end-to-end-anti-workaround-audit-v1`

**Disposition:** PASS

## Purpose

This audit is the required Phase 27 closeout review for workaround debt, duplicate authority, bypasses, and temporary repair paths. It applies the ATLAS root-cause rule: a failing invariant must be repaired at the layer that owns the defect; a bypass, relaxed validator, parallel authority path, or wrapper whose purpose is merely to produce PASS is not acceptable.

Phase 27 produced valid negative alpha evidence. The audit therefore asks whether that negative result was reached through the intended authoritative data/research path and whether any Phase 27 research component can accidentally become a trading-authority shortcut.

## Critical chain reviewed

`accepted Phase26 PIT observations -> Phase27 complete-case cross-sectional population -> nested OOS model selection -> global multiplicity control -> internal validation -> protected-blindness audit -> finalist-only protected confirmation -> independent validation -> historical support overlay`

The existing runtime authority chain was also rechecked:

`discovery/promotion -> portfolio/risk -> execution engine -> broker adapter -> operator/browser control plane`

## Findings

### 1. No parallel broker or execution authority

Phase 27 adds research/backtesting modules only. It does not add provider mutation, broker mutation, order submission, PAPER submission, LIVE execution, scheduler execution, automatic failover, or browser execution authority. The retained architecture invariant that the raw broker submit seam lives only in `packages/execution/engine.py` remains authoritative.

### 2. Phase 27 is not imported by runtime trading-authority packages

The Phase 27 research modules remain outside the routine discovery, operations, portfolio, risk, control-plane, and execution authority paths. A future supported result must be deliberately integrated by a later accepted phase; merely producing a research artifact cannot alter runtime authority.

### 3. Promotion cannot treat Phase 27 research activity as support

The accepted promotion path still requires explicit historical support evidence. No Phase 27 candidate earned support, so the negative result cannot be converted into a promotion route by fallback, “best available” selection, or threshold weakening.

### 4. Protected evidence stayed unopened

Phase 27 had zero selection survivors, zero selection winners, and zero internal finalists. The confirmation path therefore exited through `SKIPPED_ZERO_FINALISTS`, with zero protected candidate rows queried, zero protected returns read, no protected read plan, and `protected_holdout_consumed = false`.

This is a scientific preservation condition, not a loophole. The holdout may only be used by a later separately preregistered alpha phase while it remains unopened. Once any protected outcome is read, it is consumed and cannot be represented as untouched evidence again.

### 5. No runner-up or “closest model” workaround

Runner-up substitution is frozen off. A direction may advance only through its selection winner, and a failed internal winner cannot be replaced by another architecture. Phase 27 did not reinterpret near-misses as support.

### 6. Model-search scope remained finite

The frozen Phase 27 library remained eight architecture/direction hypotheses with bounded hyperparameter grids. No post-result widening of model families, hyperparameter grids, score tails, costs, chronology, confidence levels, or multiplicity treatment was performed.

### 7. Development and protected roles remain separated

The Phase 27 population builder derives a labeled development model frame and a predictors-only protected frame. The blindness audit independently proves the inherited Phase 26 holdout contained no outcome fields and had never been consumed before confirmation. The zero-finalist path never joins future outcomes.

### 8. Independent validation does not trust the cumulative summary

The independent validator reconstructs fixed-tail keys, selection/internal economics, Holm decisions, protected relationships when applicable, support authority, and artifact hashes from persisted evidence rather than accepting the cumulative runner summary as proof.

### 9. Scikit-learn deprecation was repaired at the source

The pairwise logistic ranker emitted a deprecation warning because the implementation explicitly supplied the deprecated `penalty="l2"` argument. The implementation was updated to the supported L2-equivalent API (`l1_ratio=0.0`) and regression coverage treats future `FutureWarning` output as a test failure. This is maintenance repair only; it does not alter the frozen Phase 27 candidate, hyperparameter, or statistical policy.

## Classification of recovery / compatibility mechanisms

No Phase 27 mechanism was retained merely to make a failed scientific gate pass. Resumability is limited to immutable already-persisted evidence: the cumulative runner reuses passing artifacts instead of re-drawing model selection, and protected confirmation may resume only an exact immutable read plan. These are evidence-preserving recovery properties, not alternate analytical authority.

## Closeout conclusion

No acceptance-blocking workaround, duplicate trading authority, hidden protected read, runner-up substitution path, or threshold-relaxation path was found in the Phase 27 critical chain.

The scientifically correct result remains negative: Phase 27 was executed correctly, but no frozen cross-sectional expected-return/ranking architecture earned historical analytical support. Downstream trade construction remains blocked until a separately preregistered alpha phase earns support.
